SCHEMBL2069130

SCHEMBL2069130

COC(c1ccc(-c2ccc(Cl)cc2)cc1)C1CCCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CNR1 P21554 3/20 0.46
CNR2 P34972 1/20 0.46
USP30 Q70CQ3 3/20 0.45
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
STS P08842 2/20 0.42
PTPN2 P17706 1/20 0.42
PTPN1 P18031 1/20 0.42
PTPN6 P29350 1/20 0.42
SLC6A4 P31645 1/20 0.41
HDAC4 P56524 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
ANO1 Q5XXA6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8229256 0.84 REN (0.47) USP30STSANO1
SCHEMBL13591106 0.83 ALDH1A1 (0.53) MEN1KMT2ACNR1NPC1ALDH1A1
SCHEMBL2069078 0.81 CNR1 (0.43) MEN1KMT2ACNR1CNR2USP30
SCHEMBL5582995 0.79 PTPN2 (0.48) MEN1KMT2ACNR1CNR2USP30
SCHEMBL2069204 0.76 CHEK2 (0.59) MEN1KMT2ACNR1CNR2
SCHEMBL12279408 0.75 MEN1 (0.57) MEN1KMT2ASTS
SCHEMBL2329496 0.74 MAPT (0.43) MEN1KMT2ACNR1CNR2USP30
SCHEMBL2329504 0.74 MAPT (0.43) MEN1KMT2ACNR1CNR2USP30
SCHEMBL2069131 0.74 MEN1 (0.47) MEN1KMT2ACNR1CNR2USP30
SCHEMBL2329505 0.74 MAPT (0.43) MEN1KMT2ACNR1CNR2USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative PPARA, PPARG, PPARD MEN1 3887/4885KMT2A 557/4885CNR1 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.